Liying Liu Selected Research

Serpins

1/2018	Mouse Gamma Herpesvirus MHV-68 Induces Severe Gastrointestinal (GI) Dilatation in Interferon Gamma Receptor-Deficient Mice (IFNγR-/-) That Is Blocked by Interleukin-10.
1/2018	Analysis of In Vivo Serpin Functions in Models of Inflammatory Vascular Disease.
1/2015	Serpin treatment suppresses inflammatory vascular lesions in temporal artery implants (TAI) from patients with giant cell arteritis.
9/2013	Myxomavirus-derived serpin prolongs survival and reduces inflammation and hemorrhage in an unrelated lethal mouse viral infection.
1/2012	Viral cross-class serpin inhibits vascular inflammation and T lymphocyte fratricide; a study in rodent models in vivo and human cell lines in vitro.
3/2010	Neuroserpin, a thrombolytic serine protease inhibitor (serpin), blocks transplant vasculopathy with associated modification of T-helper cell subsets.
3/2009	Myxoma viral serpin, Serp-1, inhibits human monocyte adhesion through regulation of actin-binding protein filamin B.
1/2009	The serpin saga; development of a new class of virus derived anti-inflammatory protein immunotherapeutics.
1/2008	Heparin alters viral serpin, serp-1, anti-thrombolytic activity to anti-thrombotic activity.
7/2007	Viral serpin, Serp-1, inhibits endogenous angiogenesis in the chicken chorioallantoic membrane model.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liying Liu Research Topics

Disease

27	Neoplasms (Cancer) 02/2022 - 02/2002
16	Inflammation (Inflammations) 05/2022 - 03/2006
12	Infections 08/2022 - 05/2005
12	Stomach Neoplasms (Stomach Cancer) 01/2022 - 11/2013
5	Leukemia 01/2022 - 01/2011
5	Carcinogenesis 01/2020 - 01/2017
5	Wounds and Injuries (Trauma) 09/2019 - 01/2011
4	Hemorrhage 01/2021 - 09/2013
4	Vascular System Injuries 01/2013 - 05/2003
4	Hyperplasia 01/2013 - 06/2004
4	Myxoma (Myxomas) 03/2010 - 03/2006
3	Thrombosis (Thrombus) 01/2021 - 07/2007
3	Vasculitis (Vasculitides) 01/2018 - 09/2013
3	Atherosclerosis 02/2017 - 07/2007
3	Atherosclerotic Plaque (Atheroma) 02/2015 - 07/2007
2	Neoplasm Metastasis (Metastasis) 11/2021 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 11/2021 - 11/2014
2	Starvation 01/2021 - 02/2012
2	Osteonecrosis (Kienbock's Disease) 11/2020 - 08/2012
2	Ischemia 01/2018 - 01/2011
2	Vascular Diseases (Vascular Disease) 01/2018 - 03/2010
2	Disseminated Intravascular Coagulation 09/2013 - 03/2006
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2013 - 07/2007
1	Autism Spectrum Disorder 06/2022
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 05/2022
1	Asthma (Bronchial Asthma) 05/2022
1	Chronic Pain 01/2022
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022
1	Pain (Aches) 01/2022
1	Male Infertility (Male Sterility) 01/2022
1	Lymphoma (Lymphomas) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Dysmenorrhea (Menstrual Pain) 01/2022
1	Rhinitis 07/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 07/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Memory Disorders (Memory Loss) 01/2021

Drug/Important Bio-Agent (IBA)

12	SerpinsIBA 01/2018 - 05/2003
11	Proteins (Proteins, Gene)FDA Link 05/2022 - 05/2005
10	MicroRNAs (MicroRNA)IBA 11/2020 - 11/2013
9	Biomarkers (Surrogate Marker)IBA 06/2022 - 11/2013
7	Biological ProductsIBA 01/2022 - 03/2014
5	Serine Proteases (Serine Protease)IBA 01/2014 - 05/2003
5	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 09/2013 - 03/2006
4	ChemokinesIBA 01/2017 - 06/2004
4	Apolipoproteins E (ApoE)IBA 02/2015 - 09/2007
3	RNA (Ribonucleic Acid)IBA 08/2022 - 09/2013
3	Long Noncoding RNAIBA 01/2022 - 01/2020
3	Biocompatible Materials (Biomaterials)IBA 09/2019 - 01/2017
3	HMGB1 Protein (HMG1)IBA 01/2015 - 01/2011
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 03/2010 - 05/2003
2	Messenger RNA (mRNA)IBA 08/2022 - 01/2022
2	CytokinesIBA 05/2022 - 07/2014
2	Interferon-gamma (Interferon, gamma)IBA 05/2022 - 09/2013
2	Interleukin-6 (Interleukin 6)IBA 05/2022 - 07/2021
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2011
2	SteroidsIBA 11/2020 - 08/2012
2	Sericins (Sericin)IBA 09/2018 - 04/2018
2	Interferon gamma ReceptorIBA 01/2018 - 01/2018
2	Peptides (Polypeptides)IBA 03/2016 - 09/2007
2	DNA (Deoxyribonucleic Acid)IBA 10/2015 - 01/2013
2	Immunoglobulin G (IgG)IBA 01/2014 - 01/2013
2	Carrier Proteins (Binding Protein)IBA 01/2014 - 06/2004
2	NeuroserpinIBA 09/2013 - 03/2010
2	Dacarbazine (DIC)FDA LinkGeneric 09/2013 - 03/2006
2	CalciumIBA 01/2013 - 03/2006
2	Plasminogen Activator Inhibitor 1IBA 03/2010 - 03/2009
2	Plasminogen Activators (Plasminogen Activator)IBA 03/2010 - 03/2006
2	Fibrinolysin FDA Link 03/2010 - 03/2006
2	Factor Xa (Coagulation Factor Xa)IBA 03/2010 - 03/2006
1	Interleukin-4 (Interleukin 4)IBA 05/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 02/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	UbiquitinIBA 01/2022
1	Interferon Regulatory FactorsIBA 01/2022
1	Alkylating AgentsIBA 01/2022
1	Adenosine Triphosphate (ATP)IBA 01/2022
1	Cyclin-Dependent Kinase 6IBA 01/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022
1	Testosterone (Sustanon)FDA Link 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 11/2021
1	Heparin (Liquaemin)FDA LinkGeneric 11/2021
1	Epidermal Growth Factor (EGF)IBA 11/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2021
1	CholesterolIBA 01/2021
1	Carcinoembryonic AntigenIBA 01/2021
1	P-SelectinIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Taurine FDA Link 01/2021
1	S-Adenosylmethionine (Ademetionine)IBA 11/2020
1	Histones (Histone)IBA 11/2020
1	Fibrinogen (Factor I)FDA Link 11/2020

Therapy/Procedure

10	Therapeutics 01/2022 - 02/2002
7	Drug Therapy (Chemotherapy) 02/2022 - 02/2002
2	Lasers (Laser) 01/2019 - 05/2007
1	Aftercare (After-Treatment) 01/2022
1	Acupuncture Therapy 01/2022